Tefinostat is under investigation in clinical trial NCT02759601 (Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.